Early research (Phase 1)Study completedNCT05060237
What this trial is testing
Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp
Who this might be right for
Actinic KeratosisKeratosis, ActinicKeratosis
Biofrontera Bioscience GmbH 112